As of September 2024, VistaGen Therapeutics has a market cap of $22.90M. This makes VistaGen Therapeutics the world's 21911th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $37.04M | 3.56% |
2023 | $35.77M | 66.34% |
2022 | $21.50M | -94.72% |
2021 | $407.13M | 0.52% |
2020 | $405.04M | 181.28% |
2019 | $144.00M | -54.02% |
2018 | $313.17M | 34.72% |
2017 | $232.46M | -70.15% |
2016 | $778.76M | -62.09% |
2015 | $2.05B | 15.76% |
2014 | $1.77B | 1.19% |
2013 | $1.75B | -42.47% |
2012 | $3.05B | -76.07% |
2011 | $12.74B | - |